Processa CEO buys 1,843 shares in open market

Processa Pharmaceuticals, Inc. Chief Executive Officer George K. Ng reported buying 1,843 shares of common stock in an open-market transaction at $2.97 per share.

Rhea-AI Filing Summary

Processa Pharmaceuticals, Inc. Chief Executive Officer George K. Ng reported buying 1,843 shares of common stock in an open-market transaction at $2.97 per share. Following this purchase, he holds 7,841 shares directly.

The filing also shows indirect holdings of 800 shares through the Ng Cha Family Trust and 3,488 shares through an account labeled George Ng IRRA FOB George Ng. A footnote notes an immaterial correction to a prior Form 4, adjusting an April 30, 2026 purchase to $2.71 per share and reducing that earlier trade by 15 shares.

Insider Trade Summary

Net Buyer: 1,843 shares

Net Buy 3 txns

Insider Ng George K

Role Chief Executive Officer

Bought 1,843 shs ($5K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	1,843	$2.97	$5K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 7,841 shares (Direct); Common Stock — 3,488 shares (Indirect, George Ng IRRA FOB George Ng); Common Stock — 800 shares (Indirect, Ng Cha Family Trust)

Footnotes (1)

1. F1. Shares adjusted to correct immaterial errors made on the Form 4 filed on May 1, 2026. The corrected price per share for the purchase made on April 30, 2026 is $2.71, not $2.69, which reduces the amount purchased on April 30, 2026 by 15 shares.

Key Figures

Open-market purchase: 1,843 shares Purchase price: $2.97/share Direct holdings after transaction: 7,841 shares +5 more

8 metrics

Open-market purchase 1,843 shares Common Stock bought on May 15, 2026

Purchase price $2.97/share Price for 1,843 Common Stock shares

Direct holdings after transaction 7,841 shares Common Stock held directly by CEO after May 15, 2026 trade

Indirect trust holdings 800 shares Common Stock held via Ng Cha Family Trust

Other indirect holdings 3,488 shares Common Stock held via George Ng IRRA FOB George Ng

Corrected prior purchase price $2.71/share April 30, 2026 trade corrected in footnote

Prior trade share reduction 15 shares Reduction to April 30, 2026 purchase noted as immaterial

Net buy shares 1,843 shares Net buying activity in this Form 4

Key Terms

open-market purchase, indirect ownership, Form 4, Common Stock, +1 more

5 terms

open-market purchase financial

"Purchase in open market or private transaction"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

indirect ownership financial

"ownership_type set to indirect for trust and IRRA accounts"

Form 4 regulatory

"errors made on the Form 4 filed on May 1, 2026"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Common Stock financial

"security_title listed as Common Stock in each entry"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Chief Executive Officer financial

"officer_title identified as Chief Executive Officer"

A chief executive officer (CEO) is the top leader of a company, responsible for making major decisions, setting goals, and guiding the organization’s overall direction. Think of the CEO as the captain of a ship, steering it toward success. Investors pay close attention to the CEO because their leadership and strategy can significantly influence the company's performance and future growth.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Processa (PCSA) report for CEO George Ng?

Processa reported that CEO George K. Ng bought 1,843 PCSA common shares in an open-market transaction at $2.97 per share. After this purchase, he directly owns 7,841 shares, reflecting a modest increase in his personal stake.

How many Processa (PCSA) shares does CEO George Ng own after the latest filing?

After the reported transaction, CEO George K. Ng directly owns 7,841 Processa shares. The Form 4 also lists 800 shares held via the Ng Cha Family Trust and 3,488 shares through an account labeled George Ng IRRA FOB George Ng as indirect holdings.

What price did Processa (PCSA) CEO pay for the newly purchased shares?

CEO George K. Ng purchased 1,843 Processa (PCSA) shares at an open-market price of $2.97 per share. This price reflects the cost basis for the new shares disclosed, separate from the earlier April 30, 2026 trade mentioned in the footnote.

Does the Processa (PCSA) Form 4 mention any corrections to prior insider trades?

Yes. A footnote states that shares were adjusted to correct immaterial errors in a Form 4 filed May 1, 2026. It corrects the April 30, 2026 purchase price to $2.71 per share and reduces that earlier transaction by 15 shares.

What indirect holdings of Processa (PCSA) shares are listed for CEO George Ng?

The filing lists 800 Processa shares held indirectly through the Ng Cha Family Trust and 3,488 shares held through an account described as George Ng IRRA FOB George Ng. These positions are reported as indirect ownership in addition to his direct holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/19/2026 - 06:06 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ng George K

(Last) (First) (Middle)

C/O PROCESSA PHARMACEUTICALS, INC.

601 21ST STREET SUITE 300

(Street)

VERO BEACH FLORIDA 32960

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Processa Pharmaceuticals, Inc. [ PCSA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/15/2026		P		1,843	A	$2.97	7,841(1)	D
Common Stock								3,488	I	George Ng IRRA FOB George Ng
Common Stock								800	I	Ng Cha Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares adjusted to correct immaterial errors made on the Form 4 filed on May 1, 2026. The corrected price per share for the purchase made on April 30, 2026 is $2.71, not $2.69, which reduces the amount purchased on April 30, 2026 by 15 shares.

	/s/ George Ng, by John J. Wolfel, as Attorney-in-Fact	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)